Key Account Manager - Rare Diseases - Western Germany - Nordrhein-Westfalen

The Key Account Manager (KAM) is a field-based expert, that strategically drives the commercial objectives of two rare disease drugs for Germany in the assigned territory. The KAM will be accountable for developing and implementing key account plans in their designated territory, in line with overall product strategy and in close collaboration with functions of Medical Affairs, other Commercial Roles and Market Access, while ensuring full compliance with the relevant company, industry, legal, regulatory and ethical standards.

Key Responsibilities

• Present a positive image of the company and develop awareness of Alnylam’s RNAi platform with relevant groups of healthcare professionals
• Develop, own, and drive territory and account plans, including customer targeting and cycle plan, in line with Marketing strategy and Business Operations guidance
• Achieve KPIs, including sales and volume targets
• Use advanced sales skills to ensure consistent and continuous messaging
• Perform detailed analysis of the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment
• Drive patient group identification, diagnosis and referral rates by strategic intersectoral referral network management in close cooperation with other field based functions
• Develop trusted relationships with a portfolio of customers to ensure market penetration, after developing a thorough understanding of key customer needs and requirements
• Ensure the correct products and services are delivered to customers in a timely manner by collaborating with internal stakeholders (commercial, supply chain, and compliance) and external centers
• Establish and maintain contact with key customers and provide commercial and scientific services to ensure access at site of care, and that logistics are in place to administer product
• Manage and execute local meetings to drive diagnosis and treatment rates, in collaboration with the Medical Affairs Team for physicians and other healthcare professionals
• Serve as the link of communication between key customers and internal team
• Liaise and collaborate with relevant internal staff (Medical Affairs, Field Business Leads, Sales Director, Market Access and Business Operations), as required
• Steer regular local aligment meetings with other field-based functions to ensure proper implementation and outcomes against the committed territory and account plans.
• Timely and accurate reporting and continuous diligent maintenance of the CRM database
• Conduct all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations
• Domestic travel and occasional international travel as needed
  
  

Qualifications

• University degree in a business-related field such as health or business management or comparable educational background
• Certified to promote medicinal products to national code of practice standard in Germany
• 7+ years of Sales and Key Account Management experience in bio/pharmaceutical sales
• Relationships with adult nephrologists in the area of Nordrhein-Westfalen is a plus
• Ability to gain consistent access and develop strong & professional relationships for product promotion with healthcare providers in reference centers and the community
• Effective communication and influencing skills to engage with professionals at all organizational levels
• Strong business acumen to add value to the existing healthcare structures.
• Ability to draw on previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment
• Excellent organizational and project management skills
• Fluent in German and English, both written and verbal
• Ability to travel within a territory regularly (80% of the time)
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.